About us
Wei He, MBA
Vice President of Regulatory Affairs
Worked at Betta Pharmaceutical, managed Regulatory Affairs, accomplished multiple IND/NDA/BLA, including Icotinib, Ensartinib, Bevacizumab, Befotertinib, and Vorolanib
Engaged in new drug research and development for over 20 years, focusing on drug regulatory affairs, knowledgeable in pharmaceutical product lifecycle management
Currently leading the RA team